An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

Asselah, T; Moreno, C; Sarrazin, C; Gschwantler, M; Foster, GR; Craxi, A; Buggisch, P; Ryan, R; Lenz, O; Scott, J; Van Dooren, G; Lonjon-Domanec, I; Schlag, M; Buti, M

View/Open

Published version (815.8Kb)

Volume

DOI

10.1371/journal.pone.0158526

Journal

PLOS ONE

Issue

ISSN

1932-6203

Metadata

Show full item record

Authors

Asselah, T; Moreno, C; Sarrazin, C; Gschwantler, M; Foster, GR; Craxi, A; Buggisch, P; Ryan, R; Lenz, O; Scott, J

URI

http://qmro.qmul.ac.uk/xmlui/handle/123456789/15774

Collections

Immune Systems [225]

Licence information

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.